135 related articles for article (PubMed ID: 16311769)
1. Influence of estrus status on urinary chemical parameters related to urolithiasis.
Kato Y; Yamaguchi S; Kakizaki H; Yachiku S
Urol Res; 2005 Dec; 33(6):476-80. PubMed ID: 16311769
[TBL] [Abstract][Full Text] [Related]
2. Comparison of metabolic changes for stone risks in 24-hour urine between non- and postmenopausal women.
Mai Z; Li X; Jiang C; Liu Y; Chen Y; Wu W; Zeng G
PLoS One; 2019; 14(1):e0208893. PubMed ID: 30677034
[TBL] [Abstract][Full Text] [Related]
3. The role of overweight and obesity in calcium oxalate stone formation.
Siener R; Glatz S; Nicolay C; Hesse A
Obes Res; 2004 Jan; 12(1):106-13. PubMed ID: 14742848
[TBL] [Abstract][Full Text] [Related]
4. Risk factors determining active urinary stone formation in patients with urolithiasis.
Netelenbos JC; Zwijnenburg PJ; ter Wee PM
Clin Nephrol; 2005 Mar; 63(3):188-92. PubMed ID: 15786819
[TBL] [Abstract][Full Text] [Related]
5. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
Schwille PO; Schmiedl A; Manoharan M
Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
[TBL] [Abstract][Full Text] [Related]
6. [Estimation of 24-h excretion of some promotors and inhibitors of crystallization and degree of urine saturation with calcium oxalate in calcium urinary calculi].
Boruczkowska A
Pol Arch Med Wewn; 1994 Oct; 92(4):289-98. PubMed ID: 7854956
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 24 hours urinary citrate levels in urolithiasis patients and healthy controls.
Mithani S; Zaidi Z
J Pak Med Assoc; 2005 Sep; 55(9):371-3. PubMed ID: 16302469
[TBL] [Abstract][Full Text] [Related]
8. Promoters and inhibitors of calcium urolithiasis in children.
Lama G; Carbone MG; Marrone N; Russo P; Spagnuolo G
Child Nephrol Urol; 1990; 10(2):81-4. PubMed ID: 2253256
[TBL] [Abstract][Full Text] [Related]
9. Effect of potential renal acid load of foods on urinary citrate excretion in calcium renal stone formers.
Trinchieri A; Lizzano R; Marchesotti F; Zanetti G
Urol Res; 2006 Feb; 34(1):1-7. PubMed ID: 16425021
[TBL] [Abstract][Full Text] [Related]
10. Estrogen replacement increased the citrate and calcium excretion rates in postmenopausal women with recurrent urolithiasis.
Dey J; Creighton A; Lindberg JS; Fuselier HA; Kok DJ; Cole FE; Hamm L
J Urol; 2002 Jan; 167(1):169-71. PubMed ID: 11743298
[TBL] [Abstract][Full Text] [Related]
11. Chronopharmacological studies on potassium citrate treatment of oxalocalcic urolithiasis.
Grases F; Conte A; March JG; García-Ferragut L; Villalonga N
Int Urol Nephrol; 1997; 29(3):263-73. PubMed ID: 9285296
[TBL] [Abstract][Full Text] [Related]
12. Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers.
Negri AL; Spivacow FR; Del Valle EE; Forrester M; Rosende G; Pinduli I
Urol Res; 2008 Dec; 36(6):303-7. PubMed ID: 18985334
[TBL] [Abstract][Full Text] [Related]
13. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.
Sakhaee K; Poindexter JR; Griffith CS; Pak CY
J Urol; 2004 Sep; 172(3):958-61. PubMed ID: 15311008
[TBL] [Abstract][Full Text] [Related]
14. The characteristics of the stone and urine composition in Chinese stone formers: primary report of a single-center results.
Wu W; Yang D; Tiselius HG; Ou L; Liang Y; Zhu H; Li S; Zeng G
Urology; 2014 Apr; 83(4):732-7. PubMed ID: 24485999
[TBL] [Abstract][Full Text] [Related]
15. Urinary composition in men and women and the risk of urolithiasis.
Sarada B; Satyanarayana U
Clin Biochem; 1991 Dec; 24(6):487-90. PubMed ID: 1773489
[TBL] [Abstract][Full Text] [Related]
16. Urinary metabolic evaluations in normal and stone forming children.
DeFoor W; Asplin J; Jackson E; Jackson C; Reddy P; Sheldon C; Erhard M; Minevich E
J Urol; 2006 Oct; 176(4 Pt 2):1793-6. PubMed ID: 16945651
[TBL] [Abstract][Full Text] [Related]
17. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines.
Skolarikos A; Straub M; Knoll T; Sarica K; Seitz C; Petřík A; Türk C
Eur Urol; 2015 Apr; 67(4):750-63. PubMed ID: 25454613
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for urinary stones in healthy schoolchildren with and without a family history of nephrolithiasis.
Sáez-Torres C; Grases F; Rodrigo D; García-Raja AM; Gómez C; Frontera G
Pediatr Nephrol; 2013 Apr; 28(4):639-45. PubMed ID: 23212561
[TBL] [Abstract][Full Text] [Related]
19. Clinical and metabolic evaluation of Korean patients with urolithiasis.
Park KJ; Jeon SS; Han DH; Lee SY
Scand J Clin Lab Invest; 2011 Oct; 71(6):481-5. PubMed ID: 21714706
[TBL] [Abstract][Full Text] [Related]
20. A study of the etiology of idiopathic calcium urolithiasis in children: hypocitruria is the most important risk factor.
Tekin A; Tekgul S; Atsu N; Sahin A; Ozen H; Bakkaloglu M
J Urol; 2000 Jul; 164(1):162-5. PubMed ID: 10840454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
